146 related articles for article (PubMed ID: 2509694)
1. Treatment of hidradenitis suppurativa with combination hypothalamic-pituitary-ovarian and adrenal suppression. A case report.
Camisa C; Sexton C; Friedman C
J Reprod Med; 1989 Aug; 34(8):543-6. PubMed ID: 2509694
[TBL] [Abstract][Full Text] [Related]
2. Advanced hidradenitis suppurativa of the vulva. A report of three cases.
Bhatia NN; Bergman A; Broen EM
J Reprod Med; 1984 Jul; 29(7):436-40. PubMed ID: 6481699
[TBL] [Abstract][Full Text] [Related]
3. Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy.
Sawers RS; Randall VA; Ebling FJ
Br J Dermatol; 1986 Sep; 115(3):269-74. PubMed ID: 2944535
[TBL] [Abstract][Full Text] [Related]
4. [A special aspect of perianal suppuration: Verneuil's disease].
de Ville de Goyet J; Visée P; Marbaix E; Michel L
Acta Chir Belg; 1985; 85(5):319-23. PubMed ID: 4082854
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of a persistent cyst, developing after ovarian transposition, with leuprolide acetate.
Jarrell MA; Brumsted JR
Obstet Gynecol; 1990 Nov; 76(5 Pt 2):927-8. PubMed ID: 2120646
[TBL] [Abstract][Full Text] [Related]
6. Complications of hidradenitis suppurative.
Donsky HJ
J Dermatol Surg; 1976 Nov; 2(5):362, 415. PubMed ID: 993439
[No Abstract] [Full Text] [Related]
7. Chronic hidradenitis suppurativa and perianal mucinous adenocarcinoma. A case report.
do Val IC; Almeida Filho GL; Corrêa A; Neto N
J Reprod Med; 2007 Feb; 52(2):100-2. PubMed ID: 17393769
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
Elkind-Hirsch KE; Anania C; Malinak R
J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
[TBL] [Abstract][Full Text] [Related]
9. Hidradenitis suppurativa: an androgen-dependent disorder.
Ebling FJ
Br J Dermatol; 1986 Sep; 115(3):259-62. PubMed ID: 3756090
[No Abstract] [Full Text] [Related]
10. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa.
Mortimer PS; Dawber RP; Gales MA; Moore RA
Br J Dermatol; 1986 Sep; 115(3):263-8. PubMed ID: 2944534
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis suppurativa of the anogenital region: response to isotretinoin.
Brown CF; Gallup DG; Brown VM
Am J Obstet Gynecol; 1988 Jan; 158(1):12-5. PubMed ID: 3422131
[TBL] [Abstract][Full Text] [Related]
12. Effects of gonadotropin-releasing hormone on pituitary-ovarian axis of one-year old pre-pubertal red seabream.
Kumakura N; Okuzawa K; Gen K; Yamaguchi S; Lim BS; Kagawa H
Gen Comp Endocrinol; 2004 Sep; 138(2):105-12. PubMed ID: 15302259
[TBL] [Abstract][Full Text] [Related]
13. Adrenal function under long-term raloxifene administration.
Genazzani AR; Lombardi I; Borgioli G; di Bono I; Casarosa E; Gambacciani M; Palumbo M; Genazzani AD; Luisi M
Gynecol Endocrinol; 2003 Apr; 17(2):159-68. PubMed ID: 12737677
[TBL] [Abstract][Full Text] [Related]
14. Hidradenitis suppurativa of the perineum, scrotum, and gluteal area: presentation, complications, and treatment.
Anderson BB; Cadogan CA; Gangadharam D
J Natl Med Assoc; 1982 Oct; 74(10):999-1003. PubMed ID: 7143473
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of hidradenitis suppurativa.
Rogers IW; Ryan RF
J La State Med Soc; 1983 Oct; 135(10):21-4. PubMed ID: 6557126
[No Abstract] [Full Text] [Related]
16. Host-defense mechanisms in hidradenitis suppurativa.
Dvorak VC; Root RK; MacGregor RR
Arch Dermatol; 1977 Apr; 113(4):450-3. PubMed ID: 848973
[TBL] [Abstract][Full Text] [Related]
17. The systemic effects of intra-articular corticosteroid.
Koehler BE; Urowitz MB; Killinger DW
J Rheumatol; 1974 Mar; 1(1):117-25. PubMed ID: 4459468
[No Abstract] [Full Text] [Related]
18. [Complications of hidradenitis suppurativa of the perineum].
Brink CF
S Afr J Surg; 1984 May; 22(2):109-12. PubMed ID: 6474285
[No Abstract] [Full Text] [Related]
19. Use of a gonadotropin-releasing hormone agonist in the evaluation of postmenopausal virilization due to ovarian hyperthecosis. A case report.
Koroscil TM; Harter SB; Ouweleen J; Blauer KL
J Reprod Med; 1996 Apr; 41(4):259-62. PubMed ID: 8728079
[TBL] [Abstract][Full Text] [Related]
20. Ovarian estradiol production in vivo. Inhibitory effect of leuprolide acetate.
Kowalik A; Barmat L; Damario M; Liu HC; Davis O; Rosenwaks Z
J Reprod Med; 1998 May; 43(5):413-7. PubMed ID: 9610463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
